FindTrial
Sign In

Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma: a retrospective study based on medical records.

Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma: a retrospective study based on medical records.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027406
Enrollment
Unknown
Registered
2019-11-12
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple myeloma

Interventions

MM Group:N/A

Sponsors

Jiping Wang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
32 Years to 74 Years

Inclusion criteria

Inclusion criteria: Patients who met the diagnostic criteria of MM according to the 2014 updated criteria from the International Myeloma Work Group and underwent corresponding imaging examinations were included.

Exclusion criteria

Exclusion criteria: Patients with other hematologic malignancies or malignant bone metastases were excluded.

Design outcomes

Primary

MeasureTime frame
ADC values;—

Countries

China

Contacts

Public ContactYaqiu Jiang

The First Hospital of Jilin University

13596863500@139.com+86 13596863500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026